Similar to HNSCC lines, treatment with A-485 generally led to more profound radiosensitization in CREBBP/EP300 mutant but not wild-type lung-cancer cell lines (Supplementary Fig. 6a, b). The gene discussed is EP300; the disease is lung cancer.